Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Different cities
What Is GHK-CU
In the pivotal Phase III trial that led to FDA approval, Tesamorelin reduced visceral adipose tissue (deep abdominal fat) by 15.2 percent over 26 weeks compared to a 5 percent increase in placebo
10.1080/15548627.2016.1214780 170 SimonsenA.CummingR
Discontinue use and consult a healthcare provider if you experience: Severe allergic reactions (rash, difficulty breathing, swelling), persistent injection site infections, or any concerning symptoms that do not resolve
US$ 24.88
US$ 23.87
US$ 21.66
US$ 23.76
US$ 23.89
US$ 25.45
